Document
IPR2017-01913, No. 2140-254 Exhibit - Buzdar 2001 (P.T.A.B. Nov. 17, 2017)
Cite Document
IPR2017-01913, No. 2140-254 Exhibit - Buzdar 2001 (P.T.A.B. Nov. 17, 2017)
+ More Snippets
Document
IPR2017-01913, No. 2065-179 Exhibit - Johnston 2004 (P.T.A.B. Nov. 17, 2017)
Cite Document
IPR2017-01913, No. 2065-179 Exhibit - Johnston 2004 (P.T.A.B. Nov. 17, 2017)
+ More Snippets
Document
IPR2017-01913, No. 2053-167 Exhibit - Fallowfield 2006 (P.T.A.B. Nov. 17, 2017)
Cite Document
IPR2017-01913, No. 2053-167 Exhibit - Fallowfield 2006 (P.T.A.B. Nov. 17, 2017)
+ More Snippets
Document
IPR2017-01913, No. 1086-86 Exhibit - Wilkinson, Tamoxifen Nolvadex Therapy Rationale for Loading Dose Followed by Maintenance Dose for Patients with Metastatic Breast Cancer, 10 CANCE...
Cite Document
IPR2017-01913, No. 1086-86 Exhibit - Wilkinson, Tamoxifen Nolvadex Therapy Rationale for Loading Dose Followed by Maintenance Dose for Patients with Metastatic Breast Cancer, 10 CANCER CHEMOTHERAPY
+ More Snippets
Document
IPR2017-01913, No. 1089-89 Exhibit - Chwalisz, Modulation of Oestrogenic Effects by Progesterone Antagonists in the Rat Uterus, 4 HUMAN REPRODUCTION UPDATE 570 83 1998 (P.T.A.B. A...
Cite Document
IPR2017-01913, No. 1089-89 Exhibit - Chwalisz, Modulation of Oestrogenic Effects by Progesterone Antagonists in the Rat Uterus, 4 HUMAN REPRODUCTION UPDATE 570 83 1998 (P.T.A.B. Aug. 4, 2017)
+ More Snippets
Document
IPR2017-01913, No. 2127-241 Exhibit - PDR 1999 Estrace (P.T.A.B. Nov. 17, 2017)
Cite Document
IPR2017-01913, No. 2127-241 Exhibit - PDR 1999 Estrace (P.T.A.B. Nov. 17, 2017)
+ More Snippets
Document
IPR2017-01913, No. 2094-208 Exhibit - Aulton Ch 13 (P.T.A.B. Nov. 17, 2017)
Cite Document
IPR2017-01913, No. 2094-208 Exhibit - Aulton Ch 13 (P.T.A.B. Nov. 17, 2017)
+ More Snippets
Document
IPR2017-01913, No. 2029-143 Exhibit - Osborne 2002 (P.T.A.B. Nov. 17, 2017)
Cite Document
IPR2017-01913, No. 2029-143 Exhibit - Osborne 2002 (P.T.A.B. Nov. 17, 2017)
+ More Snippets
Document
IPR2017-01913, No. 1079-79 Exhibit - Handbook of Pharmaceutical Excipients Wade ed, 2d ed 1994 (P.T.A.B. Aug. 4, 2017)
Cite Document
IPR2017-01913, No. 1079-79 Exhibit - Handbook of Pharmaceutical Excipients Wade ed, 2d ed 1994 (P.T.A.B. Aug. 4, 2017)
+ More Snippets
Document
IPR2017-01913, No. 1078-78 Exhibit - Petition for Inter Partes Review in Mylan Pharms Inc v AstraZeneca AB, Paper No 2, IPR2016 01325 PTAB June 29, 2016 (P.T.A.B. Aug. 4, 2017)
Cite Document
IPR2017-01913, No. 1078-78 Exhibit - Petition for Inter Partes Review in Mylan Pharms Inc v AstraZeneca AB, Paper No 2, IPR2016 01325 PTAB June 29, 2016 (P.T.A.B. Aug. 4, 2017)
+ More Snippets
Document
IPR2017-01913, No. 1064-64 Exhibit - Clarke, Antiestrogen Resistance in Breast Cancer and the Role of Estrogen Receptor Signaling, 22 ONCOGENE 7316 39 2003 (P.T.A.B. Aug. 4, 2017)
Cite Document
IPR2017-01913, No. 1064-64 Exhibit - Clarke, Antiestrogen Resistance in Breast Cancer and the Role of Estrogen Receptor Signaling, 22 ONCOGENE 7316 39 2003 (P.T.A.B. Aug. 4, 2017)
+ More Snippets
Document
IPR2017-01913, No. 2068-182 Exhibit - Baumann 1998 (P.T.A.B. Nov. 17, 2017)
Cite Document
IPR2017-01913, No. 2068-182 Exhibit - Baumann 1998 (P.T.A.B. Nov. 17, 2017)
+ More Snippets
Document
IPR2017-01913, No. 2138-252 Exhibit - Jonat 1996 (P.T.A.B. Nov. 17, 2017)
Cite Document
IPR2017-01913, No. 2138-252 Exhibit - Jonat 1996 (P.T.A.B. Nov. 17, 2017)
+ More Snippets
Document
IPR2017-01913, No. 2164-278 Exhibit - Sibonga 1998 (P.T.A.B. Nov. 17, 2017)
Cite Document
IPR2017-01913, No. 2164-278 Exhibit - Sibonga 1998 (P.T.A.B. Nov. 17, 2017)
+ More Snippets
Document
IPR2017-01913, No. 2062-176 Exhibit - Chia 2008 (P.T.A.B. Nov. 17, 2017)
Cite Document
IPR2017-01913, No. 2062-176 Exhibit - Chia 2008 (P.T.A.B. Nov. 17, 2017)
+ More Snippets